IQVIA Holdings (IQV) Debt/Equity Ratio: History & Chart

IQVIA Holdings Inc.(IQV)

Medical - Diagnostics & Research · Durham, NC

$255.05-4.16 (-1.60%)

Delayed quote: Sep 9, 2026, 1:04 PM EDT

About IQVIA Holdings Inc.

IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.

Durham, NC

94,000 employees

www.iqvia.com

Healthcare / Medical - Diagnostics & Research

Sector: Healthcare
Industry: Medical - Diagnostics & Research
CEO: Ari Bousbib

View full financials

IQV Debt to Equity Ratio Metrics

DEBT TO EQUITY RATIO

2.63

DEBT TO EQUITY RATIO AVG TTM

2.58

DEBT TO EQUITY RATIO AVG 3Y

2.38

DEBT TO EQUITY RATIO AVG 5Y

2.32

DEBT TO EQUITY RATIO AVG 10Y

2.02

DEBT TO EQUITY RATIO AVG 15Y

0.61

DEBT TO EQUITY RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

+2.13%

CURRENT VS 3Y AVG

+10.80%

CURRENT VS 5Y AVG

+13.28%

CURRENT VS 10Y AVG

+30.20%

CURRENT VS 15Y AVG

+334.94%

CURRENT VS 20Y AVG

N/A

SECTOR MEDIAN · HEALTHCARE

0.69

median of 84 covered companies

CURRENT VS SECTOR MEDIAN

+284.21%

vs the sector median at left

NAME	MARKET CAP	DEBT TO EQUITY RATIO	TTM	3Y	5Y
IQVIA Holdings Inc. (IQV)	$41.98B	2.63	2.58	2.38	2.32
Teva Pharmaceutical Industries Limited (TEVA)vs ›	$42.68B	2.18	2.78	2.75	2.65
Agilent Technologies, Inc. (A)vs ›	$40.97B	0.54	0.55	0.53	0.52
IDEXX Laboratories, Inc. (IDXX)vs ›	$40.82B	0.68	0.65	1.10	1.25
Humana Inc. (HUM)vs ›	$48.28B	0.74	0.74	0.75	0.72
Becton, Dickinson and Company (BDX)vs ›	$49.42B	0.69	0.79	0.73	0.74
Edwards Lifesciences Corporation (EW)vs ›	$49.65B	0.07	0.07	0.09	0.11
Alnylam Pharmaceuticals, Inc. (ALNY)vs ›	$34.19B	0.94	10.47	10.47	5.79
Alcon Inc. (ALC)vs ›	$33.55B	0.25	0.24	0.25	0.24
DexCom, Inc. (DXCM)vs ›	$31.94B	0.53	0.87	1.00	1.01

NAME

MARKET CAP

DEBT TO EQUITY RATIO

TTM

IQVIA Holdings Inc. (IQV)

$41.98B

2.63

2.58

2.38

2.32

Teva Pharmaceutical Industries Limited (TEVA)vs ›

$42.68B

2.18

2.78

2.75

2.65

Agilent Technologies, Inc. (A)vs ›

$40.97B

0.54

0.55

0.53

0.52

IDEXX Laboratories, Inc. (IDXX)vs ›

$40.82B

0.68

0.65

1.10

1.25

Humana Inc. (HUM)vs ›

$48.28B

0.74

0.75

0.72

Becton, Dickinson and Company (BDX)vs ›

$49.42B

0.69

0.79

0.73

0.74

Edwards Lifesciences Corporation (EW)vs ›

$49.65B

0.07

0.09

0.11

Alnylam Pharmaceuticals, Inc. (ALNY)vs ›

$34.19B

0.94

10.47

5.79

Alcon Inc. (ALC)vs ›

$33.55B

0.25

0.24

0.25

0.24

DexCom, Inc. (DXCM)vs ›

$31.94B

0.53

0.87

1.00

1.01

Debt to Equity Ratio FAQ

What is the debt to equity ratio for IQVIA Holdings Inc. (IQV)?

The debt to equity ratio for IQV stock is 2.63.

Is IQVIA Holdings Inc.'s debt to equity ratio high or low?

The debt to equity ratio of 2.63 is 13% above its 5-year average of 2.32, near the high end of its 5-year range (1.97–2.72).

What is the TTM average debt to equity ratio for IQVIA Holdings Inc. (IQV)?

The TTM average debt to equity ratio for IQV stock is 2.58.

What is the 3Y average debt to equity ratio for IQVIA Holdings Inc. (IQV)?

The 3Y average debt to equity ratio for IQV stock is 2.38.

What is the 5Y average debt to equity ratio for IQVIA Holdings Inc. (IQV)?

The 5Y average debt to equity ratio for IQV stock is 2.32.

What is the 10Y average debt to equity ratio for IQVIA Holdings Inc. (IQV)?

The 10Y average debt to equity ratio for IQV stock is 2.02.

What is the 15Y average debt to equity ratio for IQVIA Holdings Inc. (IQV)?

The 15Y average debt to equity ratio for IQV stock is 0.61.

DATE	DEBT TO EQUITY RATIO
2026-06-30	2.63
2026-03-31	2.58
2025-12-31	2.49
2025-09-30	2.47
2025-06-30	2.72
2025-03-31	2.43
2024-12-31	2.33
2024-09-30	1.97
2024-06-30	2.00
2024-03-31	2.17
2023-12-31	2.27
2023-09-30	2.39
2023-06-30	2.44
2023-03-31	2.26
2022-12-31	2.26
2022-09-30	2.37
2022-06-30	2.44
2022-03-31	2.19
2021-12-31	2.06
2021-09-30	2.14
2021-06-30	2.19
2021-03-31	2.11
2020-12-31	2.15
2020-09-30	2.18
2020-06-30	2.24
2020-03-31	2.27
2019-12-31	2.01
2019-09-30	1.95
2019-06-30	1.81
2019-03-31	1.77
2018-12-31	1.64
2018-09-30	1.47
2018-06-30	1.46
2018-03-31	1.27
2017-12-31	1.26
2017-09-30	1.34
2017-06-30	1.19
2017-03-31	1.10
2016-12-31	0.83
2016-09-30	-7.77
2016-06-30	-10.70
2016-03-31	-11.93
2015-12-31	-4.37
2015-09-30	-13.78
2015-06-30	-3.55
2015-03-31	-3.75
2014-12-31	-3.26
2014-09-30	-3.81
2014-06-30	-3.29
2014-03-31	-3.66
2013-12-31	-3.07
2013-09-30	-2.87
2013-06-30	-2.56
2013-03-31	-1.81
2012-12-31	-1.78
2012-09-30	0.00
2012-06-30	0.00
2012-03-31	0.00

DATE

DEBT TO EQUITY RATIO

2026-06-30

2.63

2026-03-31

2.58

2025-12-31

2.49

2025-09-30

2.47

2025-06-30

2.72

2025-03-31

2.43

2024-12-31

2.33

2024-09-30

1.97

2024-06-30

2.00

2024-03-31

2.17

2023-12-31

2.27

2023-09-30

2.39

2023-06-30

2.44

2023-03-31

2.26

2022-12-31

2.26

2022-09-30

2.37

2022-06-30

2.44

2022-03-31

2.19

2021-12-31

2.06

2021-09-30

2.14

2021-06-30

2.19

2021-03-31

2.11

2020-12-31

2.15

2020-09-30

2.18

2020-06-30

2.24

2020-03-31

2.27

2019-12-31

2.01

2019-09-30

1.95

2019-06-30

1.81

2019-03-31

1.77

2018-12-31

1.64

2018-09-30

1.47

2018-06-30

1.46

2018-03-31

1.27

2017-12-31

1.26

2017-09-30

1.34

2017-06-30

1.19

2017-03-31

1.10

2016-12-31

0.83

2016-09-30

-7.77

2016-06-30

-10.70

2016-03-31

-11.93

2015-12-31

-4.37

2015-09-30

-13.78

2015-06-30

-3.55

2015-03-31

-3.75

2014-12-31

-3.26

2014-09-30

-3.81

2014-06-30

-3.29

2014-03-31

-3.66

2013-12-31

-3.07

2013-09-30

-2.87

2013-06-30

-2.56

2013-03-31

-1.81

2012-12-31

-1.78

2012-09-30

0.00

2012-06-30

0.00

2012-03-31

0.00

Debt to Equity Ratio: 2.63

IQV Debt to Equity Ratio

IQV Average Debt to Equity Ratio Chart

IQV Current vs Average Debt to Equity Ratio Chart

IQV Debt to Equity Ratio Metrics

IQV Competitors' Debt to Equity Ratio

Financial Health

Debt to Equity Ratio Formula & Definition

Debt to Equity Ratio FAQ

IQV Debt to Equity Ratio History

Related Metrics